Question 1

What is the catalog number for 2-Cyclooctylethylamine?

Accepted Answer

The catalog number for 2-Cyclooctylethylamine is 269884.

Question 2

What sizes are available for 2-Cyclooctylethylamine?

Accepted Answer

2-Cyclooctylethylamine is available in the following size(s): 100 mg, 250 mg, 500 mg, 1 g, 2 g.

Question 3

How many pack sizes does 2-Cyclooctylethylamine come in?

Accepted Answer

2-Cyclooctylethylamine is available in 5 different pack sizes.

Question 4

Is 2-Cyclooctylethylamine in stock?

Accepted Answer

2-Cyclooctylethylamine is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 6

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 7

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

2-Cyclooctylethylamine

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Rabbit IFABP/FABP2 (Intestinal Fatty Acid Binding Protein) ValidElisa Kit

3-Hydroxyanthranilic Acid

TUBE RACK, SS

Anti-TMEFF2 Antibody Picoband®, PE Conjugate

Recombinant Nicastrin/NCSTN Monoclonal Antibody

DMBT1 (Deleted in Malignant Brain Tumors 1 Protein, GlycoProtein 340, Gp-340, Hensin, Salivary Agglutinin, SAG, Surfactant Pulmonary-Associated D-Binding Protein, DMBT1, GP340) (MaxLight 650) discontinued